Chemed Co. (NYSE:CHE) Receives $466.25 Average Price Target from Brokerages
Chemed Co. (NYSE:CHE) has received a consensus recommendation of “Hold” from the six ratings firms that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $466.25.
CHE has been the topic of several recent analyst reports. Oppenheimer increased their target price on Chemed from $440.00 to $470.00 and gave the company a “market perform” rating in a research note on Monday, November 25th. JMP Securities upgraded Chemed from a “market perform” rating to an “outperform” rating and set a $490.00 target price on the stock in a research note on Friday, November 1st. Finally, ValuEngine cut Chemed from a “hold” rating to a “sell” rating in a report on Tuesday, December 3rd.
In other news, Director Andrea R. Lindell sold 2,120 shares of the stock in a transaction on Thursday, January 23rd. The stock was sold at an average price of $480.06, for a total transaction of $1,017,727.20. Following the transaction, the director now directly owns 5,377 shares of the company’s stock, valued at approximately $2,581,282.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Naomi C. Dallob sold 660 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $433.50, for a total value of $286,110.00. Following the transaction, the vice president now directly owns 4,671 shares in the company, valued at $2,024,878.50. The disclosure for this sale can be found here. Insiders have sold a total of 6,480 shares of company stock worth $2,919,766 over the last three months. Insiders own 3.96% of the company’s stock.
CHE traded up $0.05 during trading on Friday, hitting $491.69. 159,800 shares of the company’s stock traded hands, compared to its average volume of 65,697. The company’s 50 day simple moving average is $466.03 and its two-hundred day simple moving average is $432.41. The company has a current ratio of 0.67, a quick ratio of 0.64 and a debt-to-equity ratio of 0.32. Chemed has a 12-month low of $310.28 and a 12-month high of $494.76. The stock has a market capitalization of $7.79 billion, a price-to-earnings ratio of 39.02, a PEG ratio of 2.81 and a beta of 1.07.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.